WallStreetZenWallStreetZen

NASDAQ: MGRX
Mangoceuticals Inc Stock

$0.68-0.12 (-15%)
Updated Dec 8, 2023
MGRX Price
$0.68
Fair Value Price
N/A
Market Cap
$11.52M
52 Week Low
$0.42
52 Week High
$4.37
P/E
-1.25x
P/B
8.5x
P/S
27.3x
PEG
N/A
Dividend Yield
N/A
Revenue
$496.06k
Earnings
-$7.32M
Gross Margin
59.2%
Operating Margin
-1,476.18%
Profit Margin
-1,475.2%
Debt to Equity
0.18
Operating Cash Flow
-$6M
Beta
-0.64
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

MGRX Overview

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MGRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MGRX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MGRX is poor value based on its book value relative to its share price (8.5x), compared to the US Health Information Services industry average (3x)
P/B vs Industry Valuation
MGRX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more MGRX due diligence checks available for Premium users.

Be the first to know about important MGRX news, forecast changes, insider trades & much more!

MGRX News

Valuation

MGRX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.25x
Industry
23.64x
Market
31.32x

MGRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.5x
Industry
3x
MGRX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MGRX's financial health

Profit margin

Revenue
$245.2k
Net Income
-$1.8M
Profit Margin
-734%
MGRX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MGRX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.6M
Liabilities
$240.7k
Debt to equity
0.18
MGRX's short-term assets ($1.34M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MGRX's short-term assets ($1.34M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MGRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.7M
Investing
$0.0
Financing
$0.0
MGRX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MGRX vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
MGRX$11.52M-15.50%-1.25x8.50x
OTRK$14.47M-0.94%-0.07x-3.13x
ICCT$8.56M-0.52%-0.55x1.34x
BFRG$14.69M-5.12%-2.80x3.90x
HCTI$14.78M-5.60%-1.16x2.41x

Mangoceuticals Stock FAQ

What is Mangoceuticals's quote symbol?

(NASDAQ: MGRX) Mangoceuticals trades on the NASDAQ under the ticker symbol MGRX. Mangoceuticals stock quotes can also be displayed as NASDAQ: MGRX.

If you're new to stock investing, here's how to buy Mangoceuticals stock.

What is the 52 week high and low for Mangoceuticals (NASDAQ: MGRX)?

(NASDAQ: MGRX) Mangoceuticals's 52-week high was $4.37, and its 52-week low was $0.42. It is currently -84.53% from its 52-week high and 60.95% from its 52-week low.

How much is Mangoceuticals's stock price per share?

(NASDAQ: MGRX) Mangoceuticals stock price per share is $0.68 today (as of Dec 8, 2023).

What is Mangoceuticals's Market Cap?

(NASDAQ: MGRX) Mangoceuticals's market cap is $11.52M, as of Dec 11, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Mangoceuticals's market cap is calculated by multiplying MGRX's current stock price of $0.68 by MGRX's total outstanding shares of 17,039,500.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.